AAPL333.02+3.62 (+1.10%) ▲|ABBV261.59-1.70 (-0.65%) ▼|ABT98.83-2.12 (-2.10%) ▼|ACN183.37+6.25 (+3.53%) ▲|ADBE239.94+6.77 (+2.90%) ▲|AMAT511.38-0.63 (-0.12%) ▼|AMD611.76+4.19 (+0.69%) ▲|AMGN421.51-2.13 (-0.50%) ▼|AMT163.69-1.87 (-1.13%) ▼|AMZN249.15+2.48 (+1.01%) ▲|AVGO351.19-3.91 (-1.10%) ▼|AXP304.10-1.30 (-0.43%) ▼|BA186.05-1.63 (-0.87%) ▼|BAC54.43-0.53 (-0.96%) ▼|BKNG162.91+0.57 (+0.35%) ▲|BLK1,058.29-9.65 (-0.90%) ▼|BMY62.40-0.46 (-0.73%) ▼|BNY144.63-2.35 (-1.60%) ▼|BRK-B497.95-4.40 (-0.88%) ▼|C129.48-1.32 (-1.01%) ▼|CAT810.79-15.85 (-1.92%) ▼|CL85.32-1.14 (-1.32%) ▼|CMCSA21.76+0.16 (+0.74%) ▲|COF193.07-3.39 (-1.73%) ▼|COP125.15-0.29 (-0.23%) ▼|COST910.34-14.25 (-1.54%) ▼|CRM229.57+4.26 (+1.89%) ▲|CSCO107.63+0.69 (+0.65%) ▲|CVS85.69-1.41 (-1.62%) ▼|CVX204.21-0.17 (-0.08%) ▼|DE671.55-7.33 (-1.08%) ▼|DHR221.55-4.16 (-1.84%) ▼|DIS104.90-0.51 (-0.48%) ▼|DUK114.01-0.20 (-0.18%) ▼|EMR155.10-2.14 (-1.36%) ▼|FDX285.09-2.38 (-0.83%) ▼|GD331.83-0.51 (-0.15%) ▼|GE312.29-5.60 (-1.76%) ▼|GEV950.49-12.00 (-1.25%) ▼|GILD149.05-2.23 (-1.47%) ▼|GM77.00-3.47 (-4.31%) ▼|GOOG340.74+3.42 (+1.01%) ▲|GOOGL344.08+3.16 (+0.93%) ▲|GS900.36-15.88 (-1.73%) ▼|HD284.49-3.55 (-1.23%) ▼|HON210.94+0.81 (+0.39%) ▲|IBM219.93-0.06 (-0.03%) ▼|INTC120.23+4.30 (+3.71%) ▲|INTU275.71+7.68 (+2.87%) ▲|ISRG406.63-5.55 (-1.35%) ▼|JNJ264.74-2.83 (-1.06%) ▼|JPM330.83-4.15 (-1.24%) ▼|KO86.08-0.76 (-0.88%) ▼|LIN474.65+1.28 (+0.27%) ▲|LLY1,157.08-27.55 (-2.33%) ▼|LMT509.25-2.96 (-0.58%) ▼|LOW184.29-2.97 (-1.59%) ▼|LRCX328.51+4.65 (+1.44%) ▲|MA551.47-12.11 (-2.15%) ▼|MCD230.94-3.04 (-1.30%) ▼|MDLZ57.82-0.98 (-1.67%) ▼|MDT86.29-0.80 (-0.92%) ▼|META725.18-13.61 (-1.84%) ▼|MMM164.15-4.34 (-2.58%) ▼|MO67.34-1.38 (-2.01%) ▼|MRK145.31-3.97 (-2.66%) ▼|MS188.08-4.68 (-2.43%) ▼|MSFT512.90+3.94 (+0.77%) ▲|MU1,065.11+0.03 (+0.00%) ▲|NEE75.74-0.15 (-0.20%) ▼|NFLX69.58-0.72 (-1.02%) ▼|NKE35.40-0.44 (-1.23%) ▼|NOW134.01+4.07 (+3.13%) ▲|NVDA228.38+1.17 (+0.51%) ▲|ORCL137.30-0.49 (-0.36%) ▼|PEP126.72-1.97 (-1.53%) ▼|PFE28.52-0.20 (-0.70%) ▼|PG145.28-3.04 (-2.05%) ▼|PLTR187.05+0.08 (+0.04%) ▲|PM190.82-3.08 (-1.59%) ▼|QCOM184.04-0.06 (-0.03%) ▼|RTX185.65-1.29 (-0.69%) ▼|SBUX93.96-1.47 (-1.54%) ▼|SCHW97.74-1.36 (-1.37%) ▼|SO82.89-0.56 (-0.67%) ▼|SPG200.76-3.52 (-1.72%) ▼|T24.40-0.08 (-0.33%) ▼|TMO675.05-4.56 (-0.67%) ▼|TMUS163.08+0.10 (+0.06%) ▲|TSLA354.81+1.97 (+0.56%) ▲|TXN280.09-1.60 (-0.57%) ▼|UBER68.51-0.85 (-1.23%) ▼|UNH367.08-7.86 (-2.10%) ▼|UNP272.13-2.02 (-0.74%) ▼|UPS93.44-0.49 (-0.52%) ▼|USB57.76+0.16 (+0.28%) ▲|V359.33-6.55 (-1.79%) ▼|VZ45.87-0.11 (-0.24%) ▼|WFC80.05-0.43 (-0.53%) ▼|WMT103.92-2.88 (-2.70%) ▼|XOM162.75+1.40 (+0.87%) ▲|AAPL333.02+3.62 (+1.10%) ▲|ABBV261.59-1.70 (-0.65%) ▼|ABT98.83-2.12 (-2.10%) ▼|ACN183.37+6.25 (+3.53%) ▲|ADBE239.94+6.77 (+2.90%) ▲|AMAT511.38-0.63 (-0.12%) ▼|AMD611.76+4.19 (+0.69%) ▲|AMGN421.51-2.13 (-0.50%) ▼|AMT163.69-1.87 (-1.13%) ▼|AMZN249.15+2.48 (+1.01%) ▲|AVGO351.19-3.91 (-1.10%) ▼|AXP304.10-1.30 (-0.43%) ▼|BA186.05-1.63 (-0.87%) ▼|BAC54.43-0.53 (-0.96%) ▼|BKNG162.91+0.57 (+0.35%) ▲|BLK1,058.29-9.65 (-0.90%) ▼|BMY62.40-0.46 (-0.73%) ▼|BNY144.63-2.35 (-1.60%) ▼|BRK-B497.95-4.40 (-0.88%) ▼|C129.48-1.32 (-1.01%) ▼|CAT810.79-15.85 (-1.92%) ▼|CL85.32-1.14 (-1.32%) ▼|CMCSA21.76+0.16 (+0.74%) ▲|COF193.07-3.39 (-1.73%) ▼|COP125.15-0.29 (-0.23%) ▼|COST910.34-14.25 (-1.54%) ▼|CRM229.57+4.26 (+1.89%) ▲|CSCO107.63+0.69 (+0.65%) ▲|CVS85.69-1.41 (-1.62%) ▼|CVX204.21-0.17 (-0.08%) ▼|DE671.55-7.33 (-1.08%) ▼|DHR221.55-4.16 (-1.84%) ▼|DIS104.90-0.51 (-0.48%) ▼|DUK114.01-0.20 (-0.18%) ▼|EMR155.10-2.14 (-1.36%) ▼|FDX285.09-2.38 (-0.83%) ▼|GD331.83-0.51 (-0.15%) ▼|GE312.29-5.60 (-1.76%) ▼|GEV950.49-12.00 (-1.25%) ▼|GILD149.05-2.23 (-1.47%) ▼|GM77.00-3.47 (-4.31%) ▼|GOOG340.74+3.42 (+1.01%) ▲|GOOGL344.08+3.16 (+0.93%) ▲|GS900.36-15.88 (-1.73%) ▼|HD284.49-3.55 (-1.23%) ▼|HON210.94+0.81 (+0.39%) ▲|IBM219.93-0.06 (-0.03%) ▼|INTC120.23+4.30 (+3.71%) ▲|INTU275.71+7.68 (+2.87%) ▲|ISRG406.63-5.55 (-1.35%) ▼|JNJ264.74-2.83 (-1.06%) ▼|JPM330.83-4.15 (-1.24%) ▼|KO86.08-0.76 (-0.88%) ▼|LIN474.65+1.28 (+0.27%) ▲|LLY1,157.08-27.55 (-2.33%) ▼|LMT509.25-2.96 (-0.58%) ▼|LOW184.29-2.97 (-1.59%) ▼|LRCX328.51+4.65 (+1.44%) ▲|MA551.47-12.11 (-2.15%) ▼|MCD230.94-3.04 (-1.30%) ▼|MDLZ57.82-0.98 (-1.67%) ▼|MDT86.29-0.80 (-0.92%) ▼|META725.18-13.61 (-1.84%) ▼|MMM164.15-4.34 (-2.58%) ▼|MO67.34-1.38 (-2.01%) ▼|MRK145.31-3.97 (-2.66%) ▼|MS188.08-4.68 (-2.43%) ▼|MSFT512.90+3.94 (+0.77%) ▲|MU1,065.11+0.03 (+0.00%) ▲|NEE75.74-0.15 (-0.20%) ▼|NFLX69.58-0.72 (-1.02%) ▼|NKE35.40-0.44 (-1.23%) ▼|NOW134.01+4.07 (+3.13%) ▲|NVDA228.38+1.17 (+0.51%) ▲|ORCL137.30-0.49 (-0.36%) ▼|PEP126.72-1.97 (-1.53%) ▼|PFE28.52-0.20 (-0.70%) ▼|PG145.28-3.04 (-2.05%) ▼|PLTR187.05+0.08 (+0.04%) ▲|PM190.82-3.08 (-1.59%) ▼|QCOM184.04-0.06 (-0.03%) ▼|RTX185.65-1.29 (-0.69%) ▼|SBUX93.96-1.47 (-1.54%) ▼|SCHW97.74-1.36 (-1.37%) ▼|SO82.89-0.56 (-0.67%) ▼|SPG200.76-3.52 (-1.72%) ▼|T24.40-0.08 (-0.33%) ▼|TMO675.05-4.56 (-0.67%) ▼|TMUS163.08+0.10 (+0.06%) ▲|TSLA354.81+1.97 (+0.56%) ▲|TXN280.09-1.60 (-0.57%) ▼|UBER68.51-0.85 (-1.23%) ▼|UNH367.08-7.86 (-2.10%) ▼|UNP272.13-2.02 (-0.74%) ▼|UPS93.44-0.49 (-0.52%) ▼|USB57.76+0.16 (+0.28%) ▲|V359.33-6.55 (-1.79%) ▼|VZ45.87-0.11 (-0.24%) ▼|WFC80.05-0.43 (-0.53%) ▼|WMT103.92-2.88 (-2.70%) ▼|XOM162.75+1.40 (+0.87%) ▲|
19.7 C
New York
Thursday, October 1, 2026

globenewswire

Resurgent Realty Trust Issue Position Statement Regarding Generation Income Properties, Inc. (“GIPR”)

Cites Continued Failure to Perform Fiduciary Duty by GIPR Management and Board of Directors
Cites Continued Failure to Perform Fiduciary Duty by GIPR Management and Board of Directors

22q11.2 Deletion Syndrome Market Research Report 2025: Zynerba Pharmaceuticals is at the Forefront with Its Clinical-stage Therapy Zygel (ZYN002)

22q11.2 deletion syndrome, also known as DiGeorge syndrome, is a genetic disorder caused by a chromosome 22 deletion, presenting symptoms like heart defects, immune deficiencies, and developmental delays. Market growth is driven by advancements in diagnostic technologies like next-generation sequencing (NGS) and chromosomal microarray analysis (CMA), enabling early detection and tailored interventions. Despite the lack of a cure, targeted therapies, such as Zynerba Pharmaceuticals' Zygel, are emerging. Increased awareness, research funding, and strategic collaborations are enhancing patient care and shaping a promising future for the 22q11.2 deletion syndrome market.
22q11.2 deletion syndrome, also known as DiGeorge syndrome, is a genetic disorder caused by a chromosome 22 deletion, presenting symptoms like heart defects, immune deficiencies, and developmental delays. Market growth is driven by advancements in diagnostic technologies like next-generation sequencing (NGS) and chromosomal microarray analysis (CMA), enabling early detection and tailored interventions. Despite the lack of a cure, targeted therapies, such as Zynerba Pharmaceuticals' Zygel, are emerging. Increased awareness, research funding, and strategic collaborations are enhancing patient care and shaping a promising future for the 22q11.2 deletion syndrome market.

Dr. Anosh Ahmed Announces Major Expansion of COVID Testing Contracts Across U.S. and International Markets

Dr. Anosh Ahmed expands U.S. and international COVID testing contracts with focus on compliance, fraud prevention, and trusted public health services
Dr. Anosh Ahmed expands U.S. and international COVID testing contracts with focus on compliance, fraud prevention, and trusted public health services

Lakeland Capital Welcomes 2025 Summer Interns

CHARLESTON, S.C., June 25, 2025 (GLOBE NEWSWIRE) -- Lakeland Capital, a Charleston-based private, multifamily investment company active in select East Coast markets, is pleased to welcome Margaret Cover and Michael Smyth to its 2025 summer intern class.

Crédit Agricole Brie Picardie : Informations au titre du pilier 3 au 31 mars 2025

Crédit Agricole Brie Picardie : Informations au titre du pilier 3 au 31 mars 2025

Denmark Recommerce Market Intelligence Report 2025: Value to Grow by 13.9% to Reach $1.31 Billion this Year – Trends, Opportunities and Forecast to 2029

Denmark's recommerce market is poised for robust growth, expected to reach USD 1.31 billion by 2025, with a CAGR of 11.5% from 2025-2029. This comprehensive report offers insights into market opportunities, risks, and dynamics across various consumer segments, channels, and digital platforms.
Denmark's recommerce market is poised for robust growth, expected to reach USD 1.31 billion by 2025, with a CAGR of 11.5% from 2025-2029. This comprehensive report offers insights into market opportunities, risks, and dynamics across various consumer segments, channels, and digital platforms.

Disclosure of share transfer from Inven2 AS

Issuer: Zelluna ASA
ISIN: NO0013524942
Date of transaction: 25 June 2025

AGCO Fines Wine Maker Mark Anthony Group Inc. $40,000 for undisclosed payments to retailers meant to influence sales

AGCO Fines Wine Maker Mark Anthony Group Inc. $40,000 for undisclosed payments to retailers meant to influence sales.

JAMining Launches Smart Crypto Platform for Everyone

London, UK, June 25, 2025 (GLOBE NEWSWIRE) --

JAMining, A company widely recognized for its digital asset mining services, has now created a new approach for private investors to trade cryptocurrency using a smart, automated platform. This new platform uses real-time analysis and pattern-based technologies to assist users in making smart investing decisions, without the need for specialized trading experience.

Concentrix iX Hello™ Named “Intelligent Personal Assistant of the Year” in 2025 AI Breakthrough Awards Program

Prestigious International Annual Awards Program Honors Standout AI Companies & Solutions
Prestigious International Annual Awards Program Honors Standout AI Companies & Solutions

Alectra Inc. recognized by Corporate Knights as one of Canada’s Best 50 Corporate Citizens for 2025

MISSISSAUGA, Ontario, June 25, 2025 (GLOBE NEWSWIRE) -- Alectra Inc. is ranked among Canada’s Best 50 Corporate Citizens for 2025 by Corporate Knights, marking its seventh consecutive year on the list. Alectra placed second among transmission and distribution utilities and 11th overall in the annual ranking.

Novartis completes acquisition of Regulus Therapeutics

Basel, June 25, 2025 – Novartis today announced that it has successfully completed its acquisition of Regulus Therapeutics Inc. (“Regulus”). With the completion of the acquisition, shares of common stock, par value $0.001 per share (the “Shares”), of Regulus, have ceased trading on the Nasdaq Stock Market LLC and Regulus is now an indirect wholly owned subsidiary of Novartis.

Your One-Stop Summer Shop: SHEIN’s Massive Summer Sale Has Arrived

Launching its highly anticipated Sizzling Summer Sale, SHEIN is offering Canadians up to 85% off across categories, including seasonal fashion and home

Bitcoin & Crypto Casinos: All iGaming Experts Reveal Top BTC Casinos (No KYC)!

San Diego, California, June 25, 2025 (GLOBE NEWSWIRE) --  Tell me honestly, have you ever felt like you are giving everything just for gambling? Not anymore. No KYC crypto casinos won't ask you for sensitive information like your name, address, etc. This is the reason why players are heading towards anonymous casinos. If you haven’t started your journey, are confused, or need to know more about anonymous casinos, take a moment to read this article.

- A word from our sponsors -

spot_img

Follow us